abstract |
The present invention provides anti-inflammatory compounds, comprising at least one NEMO binding domain, pharmaceutical compositions thereof, and methods of use thereof for treating inflammatory disorders. The present invention also provides methods of identifying anti-inflammatory compounds and methods of inhibiting NF-λB-dependent target gene expression in a cell. |